stoxline Quote Chart Rank Option Currency Glossary
  
Check-Cap Ltd. (CHEK)
0.9251  0.018 (1.96%)    05-16 16:00
Open: 0.8801
High: 1.06
Volume: 357,139
  
Pre. Close: 0.9073
Low: 0.8499
Market Cap: 5(M)
Technical analysis
2025-05-16 4:38:44 PM
Short term     
Mid term     
Targets 6-month :  1.4 1-year :  1.63
Resists First :  1.2 Second :  1.4
Pivot price 0.85
Supports First :  0.85 Second :  0.63
MAs MA(5) :  0.9 MA(20) :  0.81
MA(100) :  0.93 MA(250) :  1.33
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  50.9 D(3) :  49.7
RSI RSI(14): 57.4
52-week High :  3.03 Low :  0.56
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ CHEK ] has closed below upper band by 32.0%. Bollinger Bands are 35.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.06 - 1.07 1.07 - 1.07
Low: 0.84 - 0.84 0.84 - 0.85
Close: 0.92 - 0.92 0.92 - 0.93
Company Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Headline News

Thu, 01 May 2025
Check-Cap Ltd. Delays Annual Report Filing - TipRanks

Tue, 15 Apr 2025
Check-Cap Faces Nasdaq Compliance Challenge and Announces Key Appointments - TipRanks

Thu, 26 Dec 2024
Check-Cap Ltd. Approves $6M Loan to Nobul AI Corp. for Expansion - TipRanks

Tue, 24 Dec 2024
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga

Mon, 25 Mar 2024
Nobul and Check-Cap announce definitive merger agreement - Investing.com

Mon, 08 Jan 2024
symbol__ Stock Quote Price and Forecast - CNN

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 6 (M)
Shares Float 4 (M)
Held by Insiders 25 (%)
Held by Institutions 2.3 (%)
Shares Short 48 (K)
Shares Short P.Month 93 (K)
Stock Financials
EPS -2.15
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.94
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -33.3 %
Return on Equity (ttm) -53.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -2.35
Qtrly Earnings Growth 0 %
Operating Cash Flow -14 (M)
Levered Free Cash Flow -10 (M)
Stock Valuations
PE Ratio -0.44
PEG Ratio 0
Price to Book value 0.31
Price to Sales 0
Price to Cash Flow -0.39
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android